LLY
68
-2
SWK
52
-6
L
65
-4
SLB
42
-4
FOXA
59
-4
BAC
75
-3
KMI
53
-6
VLO
48
-2
FOX
60
-10
HUM
34
-8
TMO
50
-4
MDT
53
-2
CVX
23
-2
HD
31
-3
FLR
40
-2
DVN
39
-4
BEN
50
-3
DRI
56
-2
AME
66
-3
MHK
70
22
LLY
68
-2
SWK
52
-6
L
65
-4
SLB
42
-4
FOXA
59
-4
BAC
75
-3
KMI
53
-6
VLO
48
-2
FOX
60
-10
HUM
34
-8
TMO
50
-4
MDT
53
-2
CVX
23
-2
HD
31
-3
FLR
40
-2
DVN
39
-4
BEN
50
-3
DRI
56
-2
AME
66
-3
MHK
70
22
Financhill
Back

Cohen & Steers Select Preferred and Income Fund Vs. Nektar Therapeutics Industry Stock Comparison

Buy
57

PSF
Cohen & Steers Select Preferred and Income Fund

Last Price:
$20.13
Seasonality Move:
0.46%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.85
Seasonality Move:
11.58%
Buy
57
Cohen & Steers Select Preferred and Income Fund (PSF) is a Buy

Is Cohen & Steers Select Preferred and Income Fund a Buy, Sell or Hold?

  • The current Cohen & Steers Select Preferred and Income Fund [PSF] share price is $20.22. The Score for PSF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • PSF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PSF Stock Price Chart

What is Cohen & Steers Select Preferred and Income Fund's stock price today?

  • The Cohen & Steers Select Preferred and Income Fund share price today is $20.22
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSF is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

PSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 41.36 Sell
Chaikin Money Flow: -10374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.32 Sell
20-day SMA: 20.3 Sell
50-day SMA: 20.57 Sell
200-day SMA: 20.14 Buy
8-day EMA: 20.3 Sell
20-day EMA: 20.37 Sell
50-day EMA: 20.49 Sell
200-day EMA: 20.32 Sell

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Cohen & Steers Select Preferred and Income Fund Earnings Growth & PSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Cohen & Steers Select Preferred and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):